1 Product identity
Ingredient risk
1 ingredient to use with caution
Olive Leaf Andrographis
BrandAllergy Research Group→Botanical with Nutrients Tablet or Pill 10 ingredients 1 caution DSLD #304272Net contents: 90 Vegetarian Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2024-01-24
2 Ingredients (10)
IngredientGroupSafety
Microcrystalline CelluloseCellulose—
Stearic AcidStearic Acid—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⚠️ Use with caution — restricted in some markets
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
Vitamin A — Conditionally Safe
⚠ Teratogenic at high doses
⚠ Hepatotoxic with chronic excess
Vitamin C — Generally Safe
⚠ GI distress at high doses
⚠ Kidney stones risk >1g/day
Olive Leaf Extract — Limited Evidence
⚠ May lower blood pressure and glucose
⚠ GI effects
Andrographis — Conditionally Safe
⚠ GI discomfort
⚠ Headache
Calcium — Conditionally Safe
⚠ Cardiovascular risk debated >1,000 mg/day
⚠ Kidney stones
Sodium — Limited Evidence
⚠ Hypertension
⚠ Fluid retention
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
Silicon — Generally Safe
⚠ Very low toxicity
4 Label claims
• Nutrient
• All Other
• Structure/Function
5 Data source
DSLD ID304272
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2024-01-24
6 More from Allergy Research Group
View Allergy Research Group Safety Scorecard → 76 products
Acetyl-Glutathione 300 mgAdrenal CortexAller-Aid Formula IIAmmonium Chloride BufferedBrain Beef Natural GlandularBrainWave Plus7 Cite this page
Vancouver
Pkhakadze G. Olive Leaf Andrographis — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Jun 24]. Available from: https://supplement.ge/products/olive-leaf-andrographis-304272/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG